{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T00:55:28Z","timestamp":1781916928317,"version":"3.54.5"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2016,2,9]],"date-time":"2016-02-09T00:00:00Z","timestamp":1454976000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2016,2,9]],"date-time":"2016-02-09T00:00:00Z","timestamp":1454976000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1038\/leu.2016.21","type":"journal-article","created":{"date-parts":[[2016,2,10]],"date-time":"2016-02-10T09:40:23Z","timestamp":1455097223000},"page":"1624-1627","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["The landscape of myeloid neoplasms with isochromosome 17q discloses a specific mutation profile and is characterized by an accumulation of prognostically adverse molecular markers"],"prefix":"10.1038","volume":"30","author":[{"given":"M","family":"Meggendorfer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Haferlach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Zenger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Macijewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W","family":"Kern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Haferlach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,2,9]]},"reference":[{"key":"BFleu201621_CR1","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1182\/blood.V94.1.225.413k24_225_232","volume":"94","author":"T Fioretos","year":"1999","unstructured":"Fioretos T, Strombeck B, Sandberg T, Johansson B, Billstrom R, Borg A et al. Isochromosome 17q in blast crisis of chronic myeloid leukemia and in other hematologic malignancies is the result of clustered breakpoints in 17p11 and is not associated with coding TP53 mutations. Blood 1999; 94: 225\u2013232.","journal-title":"Blood"},{"key":"BFleu201621_CR2","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1046\/j.1365-2141.1999.01537.x","volume":"106","author":"RF McClure","year":"1999","unstructured":"McClure RF, Dewald GW, Hoyer JD, Hanson CA . Isolated isochromosome 17q: a distinct type of mixed myeloproliferative disorder\/myelodysplastic syndrome with an aggressive clinical course. Br J Haematol 1999; 106: 445\u2013454.","journal-title":"Br J Haematol"},{"key":"BFleu201621_CR3","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1002\/gcc.2870100402","volume":"10","author":"F Mertens","year":"1994","unstructured":"Mertens F, Johansson B, Mitelman F . Isochromosomes in neoplasia. Genes Chromosomes Cancer 1994; 10: 221\u2013230.","journal-title":"Genes Chromosomes Cancer"},{"key":"BFleu201621_CR4","doi-asserted-by":"publisher","first-page":"2879","DOI":"10.1002\/cncr.26537","volume":"118","author":"R Kanagal-Shamanna","year":"2012","unstructured":"Kanagal-Shamanna R, Bueso-Ramos CE, Barkoh B, Lu G, Wang S, Garcia-Manero G et al. Myeloid neoplasms with isolated isochromosome 17q represent a clinicopathologic entity associated with myelodysplastic\/myeloproliferative features, a high risk of leukemic transformation, and wild-type TP53. Cancer 2012; 118: 2879\u20132888.","journal-title":"Cancer"},{"key":"BFleu201621_CR5","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.cancergencyto.2005.10.004","volume":"166","author":"RF Pinheiro","year":"2006","unstructured":"Pinheiro RF, Chauffaille ML, Silva MR . Isochromosome 17q in MDS: a marker of a distinct entity. Cancer Genet Cytogenet 2006; 166: 189\u2013190.","journal-title":"Cancer Genet Cytogenet"},{"key":"BFleu201621_CR6","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"SH Swerdlow","year":"2008","unstructured":"Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, 4th ed. International Agency for Research on Cancer (IARC): Lyon, 2008."},{"key":"BFleu201621_CR7","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1111\/j.1365-2141.2009.07697.x","volume":"145","author":"V Gelsi-Boyer","year":"2009","unstructured":"Gelsi-Boyer V, Trouplin V, Adelaide J, Bonansea J, Cervera N, Carbuccia N et al. Mutations of polycomb-associated gene ASXL1 in myelodysplastic syndromes and chronic myelomonocytic leukaemia. Br J Haematol 2009; 145: 788\u2013800.","journal-title":"Br J Haematol"},{"key":"BFleu201621_CR8","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1038\/nature10496","volume":"478","author":"K Yoshida","year":"2011","unstructured":"Yoshida K, Sanada M, Shiraishi Y, Nowak D, Nagata Y, Yamamoto R et al. Frequent pathway mutations of splicing machinery in myelodysplasia. Nature 2011; 478: 64\u201369.","journal-title":"Nature"},{"key":"BFleu201621_CR9","doi-asserted-by":"publisher","first-page":"3080","DOI":"10.1182\/blood-2012-01-404863","volume":"120","author":"M Meggendorfer","year":"2012","unstructured":"Meggendorfer M, Roller A, Haferlach T, Eder C, Dicker F, Grossmann V et al. SRSF2 mutations in 275 cases with chronic myelomonocytic leukemia (CMML). Blood 2012; 120: 3080\u20133088.","journal-title":"Blood"},{"key":"BFleu201621_CR10","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/ng.2495","volume":"45","author":"R Piazza","year":"2013","unstructured":"Piazza R, Valletta S, Winkelmann N, Redaelli S, Spinelli R, Pirola A et al. Recurrent SETBP1 mutations in atypical chronic myeloid leukemia. Nat Genet 2013; 45: 18\u201324.","journal-title":"Nat Genet"},{"key":"BFleu201621_CR11","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.1038\/leu.2013.133","volume":"27","author":"M Meggendorfer","year":"2013","unstructured":"Meggendorfer M, Bacher U, Alpermann T, Haferlach C, Kern W, Gambacorti-Passerini C et al. SETBP1 mutations occur in 9% of MDS\/MPN and in 4% of MPN cases and are strongly associated with atypical CML, monosomy 7, isochromosome i(17)(q10), ASXL1 and CBL mutations. Leukemia 2013; 27: 1852\u20131860.","journal-title":"Leukemia"},{"key":"BFleu201621_CR12","doi-asserted-by":"publisher","first-page":"956","DOI":"10.3324\/haematol.2013.085217","volume":"99","author":"R Bejar","year":"2014","unstructured":"Bejar R . Clinical and genetic predictors of prognosis in myelodysplastic syndromes. Haematologica 2014; 99: 956\u2013964.","journal-title":"Haematologica"},{"key":"BFleu201621_CR13","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1038\/leu.2013.119","volume":"27","author":"AM Vannucchi","year":"2013","unstructured":"Vannucchi AM, Lasho TL, Guglielmelli P, Biamonte F, Pardanani A, Pereira A et al. Mutations and prognosis in primary myelofibrosis. Leukemia 2013; 27: 1861\u20131869.","journal-title":"Leukemia"},{"key":"BFleu201621_CR14","doi-asserted-by":"publisher","first-page":"2428","DOI":"10.1200\/JCO.2012.47.3314","volume":"31","author":"R Itzykson","year":"2013","unstructured":"Itzykson R, Kosmider O, Renneville A, Gelsi-Boyer V, Meggendorfer M, Morabito M et al. Prognostic score including gene mutations in chronic myelomonocytic leukemia. J Clin Oncol 2013; 31: 2428\u20132436.","journal-title":"J Clin Oncol"},{"key":"BFleu201621_CR15","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1002\/ajh.23755","volume":"89","author":"V Visconte","year":"2014","unstructured":"Visconte V, Tabarroki A, Zhang L, Hasrouni E, Gerace C, Frum R et al. Clinicopathologic and molecular characterization of myeloid neoplasms harboring isochromosome 17(q10). Am J Hematol 2014; 89: 862.","journal-title":"Am J Hematol"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/leu201621.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu201621","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu201621.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T00:42:39Z","timestamp":1781916159000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/leu201621"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,9]]},"references-count":15,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["BFleu201621"],"URL":"https:\/\/doi.org\/10.1038\/leu.2016.21","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,9]]},"assertion":[{"value":"9 February 2016","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"CH, WK and TH declare equity ownership of MLL Munich Leukemia Laboratory. MM, MZ and KM are employed by MLL Munich Leukemia Laboratory.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}